Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 5
2004 2
2005 6
2006 6
2007 14
2008 7
2009 10
2010 14
2011 22
2012 24
2013 40
2014 42
2015 48
2016 69
2017 75
2018 90
2019 116
2020 172
2021 187
2022 184
2023 151
2024 80

Text availability

Article attribute

Article type

Publication date

Search Results

1,205 results

Results by year

Filters applied: . Clear all
Page 1
Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy.
Linde MH, Fan AC, Köhnke T, Trotman-Grant AC, Gurev SF, Phan P, Zhao F, Haddock NL, Nuno KA, Gars EJ, Stafford M, Marshall PL, Dove CG, Linde IL, Landberg N, Miller LP, Majzner RG, Zhang TY, Majeti R. Linde MH, et al. Among authors: zhang ty. Cancer Discov. 2023 May 4;13(5):1164-1185. doi: 10.1158/2159-8290.CD-21-0502. Cancer Discov. 2023. PMID: 36856575
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
Ma X, Yang S, Zhang T, Wang S, Yang Q, Xiao Y, Shi X, Xue P, Kang Y, Liu G, Sun ZJ, Xu Z. Ma X, et al. Among authors: zhang t. Acta Pharm Sin B. 2022 Jan;12(1):451-466. doi: 10.1016/j.apsb.2021.05.016. Epub 2021 May 21. Acta Pharm Sin B. 2022. PMID: 35127398 Free PMC article.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. Among authors: zhang t. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.
Rathmell WK, Rumble RB, Van Veldhuizen PJ, Al-Ahmadie H, Emamekhoo H, Hauke RJ, Louie AV, Milowsky MI, Molina AM, Rose TL, Siva S, Zaorsky NG, Zhang T, Qamar R, Kungel TM, Lewis B, Singer EA. Rathmell WK, et al. Among authors: zhang t. J Clin Oncol. 2022 Sep 1;40(25):2957-2995. doi: 10.1200/JCO.22.00868. Epub 2022 Jun 21. J Clin Oncol. 2022. PMID: 35728020
Genitourinary cancers updates: highlights from ASCO 2023.
Qin Q, Sheffield H, Taasan SM, Wang AZ, Zhang T. Qin Q, et al. Among authors: zhang t. J Hematol Oncol. 2023 Nov 21;16(1):112. doi: 10.1186/s13045-023-01511-8. J Hematol Oncol. 2023. PMID: 37990343 Free PMC article.
1,205 results